How Science is Extending Healthspans

Emerging technological advancements are driving innovations all around us, transforming how we live, work, and interact with one another, today and in the future. In this series, Frédérique Carrier, Head of Investment Strategy, RBC Wealth Management speaks with Dr. Brian Abrahams, Global Head of Healthcare Research, RBC Capital Markets as they discuss biotech innovations as it relates to longevity.

PlayWatch video

By Brian Abrahams, M.D.
Published July 10, 2024 | 1 min read

Key Points

  • Some of the most promising biotech innovations that may improve healthspans
  • What investors should look for when investing in the biotech sector
  • Some of the most topical disruptive forces in biotech
  • How AI is changing the sector’s opportunity set

Dr. Brian Abrahams, Head of Global Healthcare Research for RBC Capital Markets, and Frédérique Carrier, Head of Investment Strategy in the British Isles and Asia for RBC Wealth Management, talk about biotech innovations related to longevity and how investors can approach this theme.

Read the full article here.

Our Experts

Brian Abrahams, M.D.
Brian Abrahams, M.D.
Managing Director, Co-Head of Biotechnology Research

Stay Informed

Get the latest insights and news from RBC Capital Markets delivered to your inbox.